[Study of a new synthetic spasmolytic (DA 3177) in emergency medicine].
D000328:Adult; D000368:Aged; D002086:Butylscopolammonium Bromide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003085:Colic / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004630:Emergencies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide
Studio di un nuovo spasmolitico di sintesi (DA 3177) in medicina d'urgenza.